545 results on '"Okuda, Seiya"'
Search Results
2. Effectiveness of cryofiltration and mizoribine combination with oral steroid therapy in a patient with membranoproliferative glomerulonephritis due to essential cryoglobulinemia
3. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis
4. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis
5. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring
6. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR)
7. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome
8. Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients
9. Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation
10. Positive association of serum levels of advanced glycation end products and high mobility group box–1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients
11. Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD)
12. Dietary Protein Restriction Rapidly Reduces Transforming Growth Factor β1 Expression in Experimental Glomerulonephritis
13. CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis
14. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease
15. Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-β1 in patients with chronic renal failure
16. Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure
17. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation
18. Assessment of therapeutic effect in patients with secondary hyperparathyroidism using bone scintigraphy
19. Evaluation of exercise-induced acute renal failure in renal hypouricemia using Tc-99m DTPA renography
20. Usefulness of whole PTH assay in patients with renal osteodystrophy —Correlation with bone scintigraphy
21. Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients
22. Effectiveness of steroid therapy in a patient with a pembrolizumab‒associated acute kidney injury
23. DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
24. Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases
25. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
26. Decreased serum carnitine is independently correlated with increased tissue accumulation levels of advanced glycation end products in haemodialysis patients
27. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients
28. Role of TGF-β1 in Experimental Glomerulonephritis
29. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
30. New pathways to renal damage: role of ADMA in retarding renal disease progression
31. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner
32. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression
33. Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner
34. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
35. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats
36. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy
37. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats
38. New Estimation Formulas for Daily Sodium Intake in Hemodialysis Patients by a Duplicate Portion Method
39. Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4
40. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease (Review Article)
41. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus
42. Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease
43. AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction
44. ANGIOTENSIN II RECEPTOR BLOCKER (ARB) LOWERS PLASMA LEVELS OF TGF-β1 IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF)
45. AN ORAL SORBENT REDUCES OVERLOAD OF INDOXYL SULFATE AND PLASMA LEVEL OF TGF-β1 IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF)
46. ADVANCED GLYCATION END PRODUCTS ACTIVATE TGF-b SIGNALING PATHWAY THROUGH RAGE-MEDIATED ROS GENERATION AND THE SUBSEQUENT ANGIOTENSIN II PRODUCTION IN CULTURED MESANGIAL CELLS
47. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: The Hisayama Study
48. Different effects of 22-oxacalcitriol and calcitriol on the course of experimental chronic renal failure
49. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis1
50. Treatment of hepatic encephalopathy by retrograde transcaval coil embolization of an ileal vein-to-right gonadal vein portosystemic shunt
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.